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Worldwide incidence of diabetes is increasing,1,2 and
about 2.3 billion people suffer from diabetes. This
number may reach 3.66 billion by 2030. The World
Health Organization (WHO) has confirmed that dia-
betes is a global disaster; 80% of the death toll in low-
and middle-income countries is associated with diabe-
tes.3 Despite the decline in the trend of pulmonary tu-
berculosis (TB), it is still one of the major causes of
death.4 Many studies have explored the relationship be-
tween the two diseases, and a recent paper showed that
diabetic patients have threefold risk of suffering from
TB than patients without diabetes.5 A survey shows
that, diabetes patients were two to four times more like-
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ly to have pulmonary TB compared with patients with-
out diabetes.4, 6-8 Currently, 90% to 95% of type 2 dia-
betes (T2DM) patients suffer from TB.4, 9-18 Some stud-
ies show that diabetes complicated with pulmonary TB
patients have significantly higher discharge of bacteria14,
19 and delay in sputum negative conversion, which lead
to the increase in drug-resistant bacteria among pa-
tients.9 These results suggest that diabetes complicated
with pulmonary TB patients pose a high risk of disease
transmission to the society. Therefore, studies on this
subject are urgently needed.
Diabetic patients are susceptible to TB. Active TB is
an infection factor that aggravates diabetes, which may
induce acute diabetic complications such as ketoacido-
sis, the treatment of which is challenging among TB
doctors. Traditional Chinese Medicine (TCM) has ac-
cumulated various treatments for diabetes and TB,
which could provide new therapeutic approaches for
personalized and comprehensive therapy. From Octo-
ber 2009 to June 2011, the author used Qi-boosting
and Yin-nourishing decoction combined with Western
Medicine in treating 30 cases of first-visit patients with
T2DM complicated with pulmonary TB.
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General information
According to the visit order and the criteria of the dis-
ease, the patients were marked 1-60, respectively. Ac-
cording to randomization table, 60 numbers were se-
lected, of which patients with odd numbers were in
treatment group administered Western conventional
regiment (WCR) plus TCM decoction, and patients
with even numbers in control group treated with
WCR alone. The WCR plus TCM group included 30
cases, with 15 male cases and 15 female cases aged 30
to 60 years (mean age of 46.3 years). Pulmonary TB
disease duration was from 3 days to 30 days (mean du-
ration of 10 days). The WRC group also included 30
cases, with 11 male cases and 19 female cases aged 28
to 62 years (mean age of 46.7 years). Pulmonary TB
disease duration was from 5 days to 40 days (mean du-
ration of 15 days). The two groups were comparable
and showed no significant difference (P < 0.05). This
study was conducted in accordance to the declaration
of Helsinki and with the approval of the Ethics Com-
mittee of Xinxiang Medical University. Written in-
formed consent was obtained from all of the partici-
pants.
Western diagnostic criteria
Diagnosis of T2DM: the diagnosis and classification
method of diabetes proposed by WHO in 199920 was
adopted in the current study. All of the patients exhibit-
ed symptoms of diabetes (polydipsia, polydipsia, and
unexplainable weight loss) and matched one of the fol-
lowing conditions: (a) fasting blood glucose (FPG) ≥
7 mmol/L; (b) random blood glucose >11.1 mmol/L;
and (c) glucose ≥11.1 mmol/L 2 h after oral glucose
tolerance test (75 g glucose).
Diagnosis of pulmonary TB: Diagnosis criteria of pul-
monary TB were based on the "classification criteria
for the diagnosis of TB in China" formulated in 1998.
All of the patients were diagnosed with more than 2 ×
sputum smear-positive acid-fast stain. X-ray analysis
confirmed the active TB disease. Initial treatment indi-
cated that the patient has never used anti-TB drugs or
has irregularly used TB drugs for no more than 1
month).
TCM diagnostic criteria
According to "Traditional Chinese Medicine of Inter-
nal Medicine",21 both Qi and Yin deficiencies are diag-
nosed as pulmonary TB. Deficiencies of Qi and Yin
syndromes include coughing and weakness, coughing
up a thin sputum, dry pharynx and arid mouth, lassi-
tude and fatigue, spontaneous perspiration and night
sweating, shortness of breath and speech sluggishness,
thirst and excessive drinking, dysphonia with feverish
sensation in the chest, palms, and soles, palpitation
and insomnia, red urine and constipation, red tongue
and lack of body fluids, big fat tongue, thin coated
tongue or flower stripping tongue, as well as small and
wiry pulse or thready rapid pulse.
Treatment
Control group: subjects received. All of the patients
were given insulin-intensive treatment. Regular insulin
was injected subcutaneously 30 min before every meal,
three times a day. Intermediate-acting insulin was sub-
cutaneous injected at 22:00 hours, and the dosage was
adjusted according to the blood sugar level. The che-
motherapy used for TB in this study was 3HRZE/
6HER (H: isoniazid; R: rifampicin; Z: pyrazinamide;
E: ethambutol). Hypotensor, lipid-lowering drugs, neu-
rotrophic drug therapy, and other drugs were selected
according to the specific circumstances of patients. Iso-
niazid tablets were provided by Beijing Yongkang Phar-
maceutical Co., Ltd., Beijing, China. Rifampicin cap-
sules were purchased from Beijing Yanjing Pharmaceu-
tical Co., Ltd., Beijing, China. Pyrazinamide was pro-
vided by Chengdu Jinhua Pharmaceutical Co., Ltd.,
Chengdu, China. Ethambutol was provided by
Shenyang Hongqi Pharmaceutical Co., Ltd.,
Shenyang, China.
Treatment group: in addition to 3HRZE/6HER plus
insulin, Qi-boosting and Yin-nourishing decoction was
administered to the group. The decoction was prepared
with Huangqi (Radix Astragali Mongolici) 30 g, Xuan-
shen (Radix Scrophulariae) 30 g, and Dihuang (Radix
Rehmanniae) 30 g, each of Cangzhu (Rhizoma Atractylo-
dis Lanceae) 10 g, Maidong (Radix Ophiopogonis Japoni-
ci) 10 g, Danggui (Radix Angelicae Sinensis) 10 g, and
Baishao (Radix Paeoniae Alba) 10 g, and of Zhimu
(Rhizoma Anemarrhenae) 6 g. Some other herbal medi-
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cations were added or removed according to the symp-
toms. If the patient was coughing up more yellow
phlegm, Sangbaipi (Cortex Mori Albae Radicis) 10 g
was added. If obvious hyperactivity of fire due to Yin
deficiency and very red tongue were observed, Huang-
bai (Cortex Phellodendri Amurensis) 6 g was added. If
dizziness, soreness, and weakness of waist and knees, as
well as deficiency of the kidney essence, were observed,
Niuxi (Radix Achyranthis Bidentatae) 15 g and Gouqizi
(Fructus Lycii) 10 g were added. If hemoptysis was ob-
served, Shanzhuyu (Fructus Corni) 20 g and calcined
Longgu (Os Draconis) 20 g were added. If loose stools,
abdominal distension, and anorexia were experienced
by the patient, Baibiandou (Semen Lablab Album) 10 g
and Yiyiren (Semen Coicis) 20 g were added. Warm de-
coctions of the medicines were taken daily during
morning and nighttime for one agent. A total of 30
days is considered as one period of treatment. Curative
effect was assessed after one period of treatment.
Curative effect
Targets of observation are as follows: (a) improvement
of the main clinical symptoms (such as cough, expecto-
ration, lassitude, spontaneous sweating, shortness of
breath, thirst and excessive drinking, dysphonia with fe-
verish sensation in the chest, palms, and soles, palpita-
tion and insomnia, red urine and constipation, palpita-
tion and insomnia, and red urine and constipation);
(b) change in fasting blood glucose measured before
and after treatment (FPG), and 2 h postprandial blood
glucose (2 hPG) level; and (c) monthly sputum smear
acid-fast bacilli and chest X-ray examination before
and after treatment.
Curative effect criteria
The criteria for curative effect of pulmonary TB were
as follows: clinical symptoms were relieved or disap-
peared; X-ray examination showed that cloudy floccule
infiltrative lesions were absorbed, dissipated, reduced,
or turned highly dense; the boundary had clear prolifer-
ative lesions, such as fibrosis and calcification; the origi-
nal tuberculous cavity was narrowed and closed; and
the sputum was negative of Mycobacterium tuberculo-
sis. The above results indicated that the patient was get-
ting better.
The criteria for the curative effect of diabetes were for-
mulated according to the "Clinical Research Guiding
Principle for Traditional Chinese Medicine in Treating
Diabetes".22 The effects were classified into three catego-
ries. (a) Obviously effective: clinical symptoms and
signs improved; FPG < 7.2 mmol/L; 2hPG < 8.3 mmol/
L, or fasting; and 2 h postprandial blood glucose values
decreased by more than 40% after the treatment.
(b) Improved: clinical symptoms and signs were re-
duced; FPG < 8.3 mmol/L; 2 h glucose decreased by
more than 20% after treatment or fasting and post-
prandial, but did not reach the effective standard.
(c) Ineffective: Improvement of clinical symptoms and
signs were not obvious or no improvement was ob-
served; FPG and 2hPG did not change or the decrease
did not reach the standard value.
Statistical analysis
Data analysis was performed with SPSS 13.0 (SPSS
Inc., Chicago, IL, USA). T-test were used to test the
differences between the two groups. P < 0.05 was con-
sidered as statistically significant.
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Lung lesion changes
In the treatment group, 25 cases of lung lesions improved
and 5 cases were ineffective, indicating an improve-
ment rate of 83.3%. In WCR group, 18 cases of lung
lesions improved and 12 cases were ineffective, indicat-
ing an improvement rate of 60%. Comparison between
WCR plusTCM group and theWCR group (Ƈ2= 4.027,
P<0.05 showedno statistical significance (Table 1).
Sputum-negative conversion
In the treatment group, 20 cases showed sputum-nega-
tive conversion and 10 cases were ineffective, indicat-
ing an improvement rate of 66.7%. In WCR group, 11
cases showed sputum-negative conversion and 19 cases
were ineffective, indicating an improvement rate of
36.7%. Comparison between WCR plus TCM group
and WCR groups (Ƈ2 = 8.25, P < 0.05) showed statisti-
cal significance (Table 2).
Curative effect
In the treatment group, 20 cases were obviously effec-
tive, 7 cases improved, and 3 cases were ineffective, in-
dicating a total efficiency of 90% . In WCR group, 9
cases were obviously effective, 14 cases improved, and
7 cases were ineffective, indicating an improvement rate
of 76.7% . Comparison between the two groups (Ƈ2 =
28.2, P < 0.05) showed statistical significance (Table 3).
Glycemic parameters
Comparison of the fasting blood glucose after treat-
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Group
WCR+TCM
WCR
n
30
30
Effective (cases)
25
18
Ineffective (cases)
5
12
Total effective rate (%)
83.3a
60.0
Notes: WCR+TCM: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 g qd plus Qi-boosting and
Yin-nourishing decoction; WCR: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 qd. A total of
30 days. WCR: western conventional regiment; TCM: Traditional Chinese Medicine. Compared with WCR group, aP < 0.05.
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ment between WCR plus TCM group and WCR
group (t = 啾2.092, P < 0.05) showed no significant
difference, whereas the comparison of 2 h postprandial
blood glucose after treatment between WCR plus
TCM group and WCR group (t =啾7.602, P < 0.001)
showed significant difference (Table 4).
±s)
%*4$644*0/
Diabetes has mutual clinical influence with TB, which
is very difficult to treat. According to a study,23 patients
with diabetes are 3.5 times more at risk in having new
pulmonary TB than nondiabetic patients and that the
TB morbidity rate of patients with diabetes is 4.8
times higher than that of the general population. The
effect of diabetes on TB and its mechanism is generally
believed to be associated with the following: (a) disor-
der of glucose metabolism and too high blood glucose
in diabetic patients, resulting in reduced white blood
cell lysis and in vivo bactericidal ability, which are con-
ducive to growth and reproduction of M. tuberculosis;
(b) fat metabolism disorder, which exhibits high triglyc-
eride and cholesterol levels, as well as pyruvimia, which
can promote the growth of M. tuberculosis; (c) de-
crease in the synthesis of vitamin A, in which the liver
conversion of carotene into vitamin A is dysfunctional,
causing vitamin A deficiency, which eventually leads to
a decrease in respiratory resistance to infection; (d) de-
creased immunity, in which protein metabolism distur-
bance in patients with diabetes may influence abnor-
mal synthesis and function of immunoglobulin, there-
by affecting lymphocyte transformation (abnormal hu-
moral and cell immunity functions are the main rea-
sons for susceptibility to TB); and (e) diabetes, which
can cause pulmonary microvascular disease, wherein
the total lung capacity and diffusion function of pa-
tients may decrease and hypoxemia may occur, thereby
stimulating the growth of M. tuberculosis.
TB-poisoning symptoms may affect the function of
the pancreatic islet and insulin, which can aggravate
the symptoms of diabetes. Anti-TB drugs can reduce
or increase some of the hypoglycemic complications. A
more effective treatment is needed to address this prob-
lem.
Diabetes is described as the "consumptive thirst" in
terms of TCM. It recognizes diabetes as a disease that
is always complicated with pulmonary TB. The "Con-
fucian Treating Filialition, Three Consumption-Symp-
tom Theory of Liu Hejian24 describes the disease as
"steaming hot sweats or night sweat, atropic lung dis-
ease, and severe coughing". TCM recognizes that con-
genital deficiency, improper diet, emotional disorders,
or warm, dry drugs are important factors in the occur-
rence of consumptive thirst. Loss of body fluids and
hot endogenous are basic pathological symptoms of
consumptive thirst. Excessive fire-consuming Qi result-
ing in Qi deficiency is the pathogenic characteristic of
diabetic patients. For pulmonary TB, TCM recognizes
that "consumptive thirst mainly represents Yin deficien-
cy", which means that because of the invasion of the
Group
WCR+TCM
WCR
n
30
30
FPG (mmol/L)
Before treatment
8.5±0.7
8.4±0.8
After treatment
5.8±0.5a
6.8±0.5
2HPG (mmol/L)
Before treatment
12.8±1.4
12.7±1.2
After treatment
8.4±0.9b
10.6±1.3
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Notes: WCR+TCM: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 g qd plus Qi-boosting and
Yin-nourishing decoction; WCR: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 qd. A total of
30 days.WCR: Western conventional regiment; TCM: Traditional Chinese Medicine. aP < 0.05 compared with WCR group; bP < 0.01
compared with WCR group.
Group
WCR+TCM
WCR
n
30
30
Obvious effective (cases)
20
9
Improved (cases)
7
14
Ineffective (cases)
3
7
Total effective rate (%)
90.0%
76.7%
Notes: WCR+TCM: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 g qd plus Qi-boosting and
Yin-nourishing decoction; WCR: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 qd. A total of
30 days. WCR: Western conventional regiment; TCM: Traditional Chinese Medicine.
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Group
WCR+TCM
WRC
n
30
30
Negative (cases)
20
11
Positive (cases)
10
19
Negative conversion rate (%)
66.7a
36.7
Notes: WCR+TCM: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 g qd plus Qi-boosting and
Yin-nourishing decoction; WCR: insulin, isoniazid 0.3 g qd, rifampicin 0.45 g qd, pyrazinamide 0.5 g tid, ethambutol 0.75 qd. A total of
30 days. WCR: Western conventional regiment; TCM: Traditional Chinese Medicine. Compared with WCR group, aP < 0.05.
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TB-causing organism and other pathogenic factors, the
Qi will be deficient. The author observed in T2DM
complicated with pulmonary TB patients that clinical
manifestations of Qi and Yin deficiency syndromes are
common. The key to the treatment of diabetes compli-
cated with pulmonary TB is to control blood sugar, so
that anti-TB treatment can achieve curative effect. In
the Qi-boosting and Yin-nourishing decoction,
Huangqi (Radix Astragali Mongolici) complements the
gas of the spleen and lung, invigorates Qi for consoli-
dating superficies, as well as raises Yang and lifts pro-
lapsed zang-fu organs while promoting pus discharge
and tissue regeneration. Huangqi (Radix Astragali Mon-
golici) is a superior medicine that can enhance body im-
munity, lower blood glucose, and can be directed
against the tendency of diabetes complicated with TB
to form a cavity. Maidong (Radix Ophiopogonis Japoni-
ci) and Dihuang (Radix Rehmanniae) can nourish Yin
of the lung, stomach, and kidney, as well as clear heat
and release latent heat. Xuanshen (Radix Scrophulariae)
is salty and cold, and has the power of purging fire to
remove toxins and resolve hard lumps, which can cure
steaming bone and TB cough. Zhimu (Rhizoma Ane-
marrhenae) is sweet, cold, and moist, which can purge
lung fire, nourish lung and stomach Yin, purge kidney
Yang and stomach fire, and nourish kidney Yin. Dang-
gui (Radix Angelicae Sinensis) and Baishao (Radix Pae-
oniae Alba) can nourish blood, promote blood circula-
tion, and astringe Yin to the liver to prevent
wood-fire-impaired metal. Cangzhu (Rhizoma Atractyl-
odis Lanceae) can invigorate the spleen and eliminate
dampness, which can help transport cold agents to pre-
vent stomach ache. Huangqi (Radix Astragali Mongoli-
ci) with Dihuang (Radix Rehmanniae) and Xuanshen
(Radix Scrophulariae) with Cangzhu (Rhizoma Atractylo-
dis Lanceae) of Chinese Atraxtylode are hypoglycemic
prescriptions posited by Shi Jinmo and Zhu Shenyu.
The two can reduce blood and urine sugar. They used
together can boosts Qi, nourishes Yin, and clears heat,
which treat both the manifestation and the root cause
of the disease. These effects are advantageous in heal-
ing pulmonary TB, reducing blood sugar, and prevent-
ing complications. In this study, the patients in the
treatment group exhibited better results that WCR
group in terms of improvement of symptoms, blood
glucose control, lung lesion absorption, sputum-nega-
tive conversion, and in other criteria. No serious ad-
verse reaction was observed. Therefore, the combina-
tion of TCM decoction and WCR in the treatment of
diabetes complicated with pulmonary TB can better
control blood sugar, accelerate sputum-negative conver-
sion, increase sputum bacteria negative conversion
rate, promote focus absorption, improve symptoms,
boost Qi, and nourish Yin.
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